NextCure, Inc. insiders: buys and sells · NXTC

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-23 and 2026-10-27. All filings on SEC EDGAR →

Bought: $53,691
Sold: $0
Buys: 3
Sells: 0

The 3 transactions

Date	Who	Role	Transaction	Shares	Price	Amount
2026-10-27	Adar1 Capital Management, Llc	10%+ owner	buy	3.553	5,0953	$18,104
2026-10-26	Adar1 Capital Management, Llc	10%+ owner	buy	1.672	5,0344	$8,418
2026-10-23	Adar1 Capital Management, Llc	10%+ owner	buy	5.626	4,8294	$27,170

How to read these transactions

There are 3 filed transactions for NextCure, Inc. (NXTC) between 2026-10-23 and 2026-10-27. All of them are by the same person. Open-market buys: 3, for $53,691. Sells: 0, for $0.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

Nayax Ltd. (NYAX) · Nuveen Municipal Credit Income Fund (NZF) · REALTY INCOME CORP (O) · Orchestra BioMed Holdings, Inc. (OBIO) · OCEANFIRST FINANCIAL CORP (OCFC) · Ocugen, Inc. (OCGN) · OCULAR THERAPEUTIX, INC (OCUL) · Oil-Dri Corp of America (ODC)

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account